-
421
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Get full text
Article -
422
-
423
-
424
Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models
Published 2017-01-01Get full text
Article -
425
Applying ‘cultural humility’ to occupational therapy practice: a scoping review protocol
Published 2022-07-01Get full text
Article -
426
-
427
-
428
-
429
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
430
-
431
Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma
Published 2024-12-01Get full text
Article -
432
Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?
Published 2025-01-01Get full text
Article -
433
Optimizing electrode configurations for EEG mild cognitive impairment detection
Published 2025-01-01Get full text
Article -
434
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Published 2025-01-01Get full text
Article -
435
-
436
-
437
Development of a checklist for cognitive assessment requirements (CARE) based on a Delphi consensus study
Published 2025-01-01Get full text
Article -
438
-
439
-
440
Impact of cigarette taxes and prices in Latin America tobacco smoking prevalence: A systematic review
Published 2024-09-01Get full text
Article